DSM Biologics to Acquire Rhobust(TM) Technology from Upfront Chromatography A/S

Tuesday, May 4, 2010 General News
Email Print This Page Comment
Font : A-A+

For more information:

Rolf Douwenga

Spencer Reynolds

Vice President, Research and Development

Director, New Business Development

DSM Biologics

DSM Biologics

Tel: +1-973-257-8220

Tel: +1-973-257-8056

Rolf.Douwenga@dsm.com

Spencer.Reynolds@dsm.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook